Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000902219-25-000364·MBX Biosciences, Inc.
Schedule 13G ownership disclosure
MBX Biosciences Inc
Common Stock · CUSIP: 55287L101
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Wellington Management Group LLP
Shares: 4,823,336.00 · Class: 10.8%
- Wellington Group Holdings LLP
Shares: 4,823,336.00 · Class: 10.8%
- Wellington Investment Advisors Holdings LLP
Shares: 4,823,336.00 · Class: 10.8%
- Wellington Management Company LLP
Shares: 4,823,336.00 · Class: 10.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-25-000364
- Form type
- SCHEDULE 13G/A
- Filer
- MBX Biosciences, Inc.
- CIK
- CIK 1776111
- Filed
- Oct 06, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership